Latest News about JNJ
Recent news which mentions JNJ
3 Top Healthcare Stocks to Buy for April
April 04, 2023
From Motley Fool
3 Dow Stocks That Are Screaming Buys in April
April 04, 2023
From Motley Fool
From Motley Fool
From Motley Fool
From Motley Fool
3 Warren Buffett Stocks That Are No-Brainer Buys in April
April 03, 2023
From Motley Fool
From Motley Fool
3 Surprisingly Underrated Stocks to Buy in April
April 01, 2023
From Motley Fool
From InvestorPlace
From MarketWatch
The 3 Best Stocks to Buy if You Want to Retire Early
March 30, 2023
From InvestorPlace
2 Unstoppable Stocks to Buy Without Hesitation Right Now
March 30, 2023
From Motley Fool
Johnson & Johnson Pulls Plug On Large Late-Stage Study Of RSV Vaccine Candidate; GSK, Pfizer Shots Are Under FDA Review
March 29, 2023
From Benzinga
From Benzinga
From Motley Fool
From Motley Fool
7 Dividend Aristocrats to Buy for Consistent Income Growth
March 28, 2023
From InvestorPlace
From Motley Fool
From Motley Fool
3 Blue-Chip Stocks to Buy for Stability and Safety
March 27, 2023
From InvestorPlace
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
March 27, 2023
From Benzinga
Better Buy: AbbVie vs. Johnson & Johnson
March 25, 2023
From Motley Fool
Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories
March 24, 2023
From Benzinga
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India, Makes Way For Domestic Generic Players
March 24, 2023
Tickers
JNJ
From Benzinga
Have $1,000? 2 Smart Stocks to Buy This Month
March 23, 2023
From Motley Fool
3 Safe Dow Dividend Stocks to Buy Now
March 23, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.